Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy
To achieve superior therapeutic efficacy, the combination chemotherapy using two or more anticancer drugs in clinical practice has been generally accepted as a feasible strategy. On account of the concept of combination chemotherapy, co-delivery of anticancer drugs with nanotechnology gradually beco...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_ca31c82f95b54d309a3fef5c0b0d5a72 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Shan-Shan Qi |e author |
| 700 | 1 | 0 | |a Jia-Hui Sun |e author |
| 700 | 1 | 0 | |a Hao-Han Yu |e author |
| 700 | 1 | 0 | |a Shu-Qin Yu |e author |
| 245 | 0 | 0 | |a Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy |
| 260 | |b Taylor & Francis Group, |c 2017-01-01T00:00:00Z. | ||
| 500 | |a 1071-7544 | ||
| 500 | |a 1521-0464 | ||
| 500 | |a 10.1080/10717544.2017.1410256 | ||
| 520 | |a To achieve superior therapeutic efficacy, the combination chemotherapy using two or more anticancer drugs in clinical practice has been generally accepted as a feasible strategy. On account of the concept of combination chemotherapy, co-delivery of anticancer drugs with nanotechnology gradually becomes a desired strategy and one of the research frontiers on modern drug delivery. In recent years, nano drug co-delivery system (NDCDS), which loads at least two anticancer drugs with different physicochemical and pharmacological properties into a combination delivery system, has achieved rapid development. NDCDS synergistically inhibited the growth of the tumor compared with the free drugs. In this review, we highlighted the current state of co-delivery nanoparticles and the most commonly used nanomaterial, discussed challenges and strategies, and prospect future development. | ||
| 546 | |a EN | ||
| 690 | |a combination chemotherapy | ||
| 690 | |a nano drug co-delivery system (ndcds) | ||
| 690 | |a multidrug resistance (mdr) | ||
| 690 | |a targeting nanoparticles | ||
| 690 | |a drug delivery materials | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Drug Delivery, Vol 24, Iss 1, Pp 1909-1926 (2017) | |
| 787 | 0 | |n http://dx.doi.org/10.1080/10717544.2017.1410256 | |
| 787 | 0 | |n https://doaj.org/toc/1071-7544 | |
| 787 | 0 | |n https://doaj.org/toc/1521-0464 | |
| 856 | 4 | 1 | |u https://doaj.org/article/ca31c82f95b54d309a3fef5c0b0d5a72 |z Connect to this object online. |